CURRICULUM VITA

ACTIVITIES AND PUBLICATIONS

K Rivet Amico, PhD

Associate Professor
University of Michigan
Department of Health Behavior and Health Education

3830 School of Public Health

1415 Washington Heights
Ann Arbor, Michigan 48109-2029
T: 810 360 8716
F: 734 763 7379
ramico@umich.edu

[Updated May 2018 K. Rivet Amico, PhD]

EDUCATION
University at Albany, State University of New York
Ph.D. in Counseling Psychology (APA approved)
August, 1998

University of Delaware
B.A. in Psychology with Distinction
June, 1991 Magna Cum Laude

EMPLOYMENT
Research Associate Professor University of Michigan, School of Public Health, Department of Health Behavior
Health Education (8/2014-12/31/2018)

Associate Professor University of Michigan, School of Public Health, Department of Health Behavior Health
Education (1/1/2018 - Present)

LLC, Applied Health Research (2009 – present)

RESEARCH EXPERIENCE [past 10 years]

01/18 – present School of Public Health, University of Michigan, Ann Arbor, MI.
Associate Professor with Tenure
Engaged in instruction and research with the Department of Health Behavior and Health Education. Develop and
maintain active research program focused on health promotion in marginalized populations domestically and
internationally.

08/14 – 1/18 School of Public Health, University of Michigan, Ann Arbor, MI.
Research Associate Professor

1
Participation/contribution on multiple projects targeting health behavior and decision making in the areas of HIV-
prevention and treatment, with specialization in medication and biomedical adherence, linkage/retention in HIV care,
and the application of social behavioral models and interventions to the promotion of health in diverse populations.

11/09 – 7/14 Center for Health, Intervention and Prevention, University of Connecticut, Storrs, CT.
Research Scientist
Development and management of several areas of research, including antiretroviral adherence (theory development
and testing, intervention development, synthesis and review of literature, and applications to adherence in the context
of clinical trials), care initiation and maintenance for chronic conditions (including HIV-care model development and
assessment, and intervention development), and methodological and statistical considerations and applications to
health promotion research and its dissemination. This position also includes student mentoring and support in the
development of new areas of inquiry that use theory based approaches to understand and support changes in health
behavior and risk reduction. Additional research programs under development include the refinement and evaluation of
Next-Step Counseling as a tool to support PrEP use and its application to ARV adherence, as well as the use of this and
other brief intervention approaches in supporting timely entry into HIV-care and maintenance in care once initiated.

9/06 -- 11/09 Center for Health, Intervention and Prevention, Department of Psychology, University of Connecticut,
Storrs, CT.
Assistant Research Professor
Coordination of several adherence (HIV medications) and resistance data sets and associated analyses, intervention
development for existing projects targeting adherence to treatment for HIV care and prevention strategies for HIV, TB,
diabetes complications, and childhood overweight, identification of new innovating strategies for intervention at point
of service within healthcare systems, development of explanatory models of engagement in care, methodological
evaluations of new and emerging projects, and initiation of new projects via multidisciplinary collaborations and well
recognized funding agencies. Additionally, mentoring of graduate students at the Center in their dissertation, masters,
and independent project work.

CONSULTANCY (Applied Health Research, LLC)

• Prevention Needs of HIV+ Persons Awaiting Release from Prison [NIH, R03, PI- Sheryl Catz, Center for Health
Studies]- consultant for methods, measures and intervention development
• Test of an intervention to improve retention in HIV care after hospitalization [NIMH R34, PI- Thomas Giordano,
Baylor College] - consultant for methods, measures and intervention development
• Internet Medication Adherence Study [NIMH R34, PI- Keith Horvath, University of Minnesota]- consultant for
measures development.
• The iPrEx Study [NIMH, CDC, Gates Foundation, PI- Robert Grant, Gladstone Institute] Consultant for adherence
support approach development, deployment, and implementation.
• VOICE Trial [MTN, FHI] Consultant for the development and implementation of a needs assessment based
revision to adherence support approach- Voice Adherence Strengthening Program
• ATN [103/110] Consultant for training study team on NSC/iNSC
• CHRP PATH Project [Los Angeles] Consultant for training study team on iNSC
• CHRP CRUSH Project [Oakland] Consultant for training study team on iNSC
• The Sabes Project [Peru] Consultant for Ann Duerr [PI] project to identify acute cases of HIV among MSM in Lima
and link, treat and retain them in HIV care.

CLINICAL EXPERIENCE
5/99 – 2/00 DC Commission on Mental Health Services Clinical Psychologist. Saint Elizabeth’s Hospital, Acute Youth

2
 and Adolescent Inpatient Branch. 202-373-7100.
Child and Adolescent Inpatient Clinician, Full Time experience. Supervised by David Berndt, Ph.D.
Interdisciplinary team member in providing services to an inpatient, inner-city, economically
disadvantaged population ranging in age from 6 to 17 years old. Responsibilities included court-
mandated assessment of personality and cognitive functioning, individual and play therapy, group
therapy for latency aged youth and adolescent substance abusers, family therapy, and development and
coordination of system-wide behavior management plan. Also developed a crisis intervention decision-
tree, system-wide intervention plan for occurrences of violent and non-violent defiant behavior, and
behavior management system.

9/98 - 2/99 CT Post-Doctoral Training, West Hartford’s Psychological Health Associates. Hiring Partner- David
Greenfield, Ph.D. 860-233-9772.
Clinician, Full Time experience. Supervised by G. Grant Holtzberg, Ph.D.
Six month training in provision of mental health services to individuals in the West Hartford and
Danbury, CT area.

9/97 - 8/98 APA Approved Clinical Internship, Northport Veteran=s Administration and Medical Center. Training
Director, Janet Eschen, Ph.D. 516-261-4400 (2258)
Rotations in primary care, Mental Hygiene Clinic, psychiatric inpatient, neuropsychology, health
psychology, geriatric psychology, and substance abuse.

ACTIVE RESEARCH FUNDING [9 active projects; 2 in process of activating; 3 PI/Chair, 2 M-PI/Co-chair]

U24HD089880-01 Amico (PI) 09/30/16-05/31/18 2.00 calendar

UNC/NICHD $1,038,127 DC
Triggered escalating real-time adherence intervention to promote rapid HIV viral suppression among youth living with
HIV failing first line antiretroviral therapy: The TERA Intervention
The goal of this is to evaluate the efficacy of an intervention for youth failing first-line ART due to non-adherence that
uses intensive coaching and electronic drug monitoring for 12 weeks followed by observation for a total of 48 weeks on
viral suppression. This project is being implemented within the new ATN structure.
Role: PI

1-R01-DA-039950-01 Horvath (PI) 07/01/15-05/31/18 0.60 calendar

U of Minnesota/NIH $42,168 DC
A Technology-delivered Peer-to-Peer Support ART Adherence Intervention for HIV+ MSM
The goal of this proposed project is to fully evaluate our piloted social networking intervention targeted improved
adherence, retention and general self-care among MSM who are HIV positive in the US.
Role: Co-I

5-R01-MH-107275-02 Chang (PI) 05/07/15-04/30/19 0.60 calendar

Johns Hopkins/NIH $25,553 DC
CHWs, mHealth, and Combination HIV Prevention in a Hotspot: A Randomized Trial
The goal of this project is to engage high prevalence communities in HIV-treatment and prevention through use of
community health workers using a mobile health tool that assists counselors in targeting prevention needs and links
participants to tailored unmet needs.
Role: Co-I

3
UM1-AI-068632 Amico (PI) 04/01/15-11/30/2018 1.20 calendar
Johns Hopkins University School of Medicine/NIH $40,174 DC
IMPAACT Network Adherence Working Group Chair.
The goal of this project is to lead an adherence working group within the IMPAACT trials network to provide support for
network projects as well as propose independent network projects that address adherence to HIV treatment in expecting
women, children and adolescents living with HIV.
Role: Chair/PI

UM1-AI-068619 Amico (PI) 12/01/15-05/31/18 0.60 calendar

FHI 360/NIH $88,101 DC
Validation of sexual and adherence behavior questions through cognitive testing
The goal of this project is to perform cognitive testing on items commonly used to assess sexual risk behavior,
adherence and risk perception in heavily researched populations in Cape Town and KZN South Africa to produce items
that have strong alignment between participant-understanding and item intent.
Role: PI

1R01AI124413-01 O’Donnell (PI) 04/10/16-03/31/21 1.00 calendar

Columbia University $35,388 DC
Promoting engagement in the drug-resistant TB/HIV care continuum in South Africa
This goal of this project is to evaluate a patient-centered program for X/MDR-TB patients through the process of
treatment (inpatient and outpatient) using mixed methods to identify gaps in care and engaging hospital care teams and
community groups to bridge them. This work takes place in KZN, South Africa.
Role: Co-I

4-R01-AI-103661-05 Mugavero (PI) 08/01/14 – 05/31/18 1.36 calendar

University of Alabama/NIH-NIMH $139,286 DC
Integrating ENGagement and Adherence Goals upon Entry (iENGAGE) is an intervention delivered during the first 12
months of HIV-care to promote rapid and sustained viral suppression.
The goal of this study is to facilitate patient adjustment to a new diagnosis of HIV infection and to develop the necessary
patient motivation and skills for optimal adherence to HIV care and ART.
Role: Co-I

1-R01-MH-113478-01 Audet (PI) 05/12/17-05/30/20 0.24 calendar

Vanderbilt Institute for Global Health/NIH $9,646 DC
Partners-based HIV Treatment for Sero-concordant Couples attending Antenatal Care.
The goal of this project is to evaluate a couple’s focused intervention to promote adherence and viral suppression
among couples attending antenatal care services in Mozambique.
Role: Co-I

5-U19-HD-089881-02 Horvath/Amico (PIs) 09/30/16-05/31/18 1.20 calendar

The University of North Carolina at Chapel Hill $31,399 DC
The UNC/Emory Center for Innovative Technology (iTech) across the prevention and care continuum
As part of the UNC/Emory Center for Innovative Technology (iTECH) across the prevention and care continuum, youth
thrive with me (YouThrive) evaluates the impact of this web-enabled app on viral suppression among youth living with
HIV.
Role: Multiple-PI

4
IN PROCESS OF ACTIVATING
Hoenigl (PI) 04/01/18-03/31/20 1.80 calendar
University of California, San Diego $76,407 DC
Perception of repeated negative HIV test results in men who have sex with men
The goal of this study is to assess perceptions of negative HIV test results and how they are associated with HIV risk
behaviors over time in MSM seeking repeat HIV testing. The proposed study will provide critically important information
related to the motivations behind risk behavior in these MSM, and will inform strategies to modify or develop
prevention interventions for HIV-negative MSM during repeat HIV testing and counseling sessions.
Role: Co-I

O’Donnell and Amico (MPIs) 04/01/18-03/31/20 1.20 calendar

Columbia University $57,301 DC
Impact of a multimodal intervention to reduce dual stigma and improve treatment outcomes in HIV/Drug-resistant TB co-
infected patients in KwaZulu-Natal, South Africa. The goal of this study is to assess intersectional stigma for people living
with HIV and drug resistant TB in KZN. Impact of our on-going intervention on stigmas will be evaluated.
Role: M-PI

PENDING

Audet (PI) 09/01/18-8/30/23 1.20 calendar

Vanderbilt University $181,481 DC
Partners-based PrEP during Pregnancy and Lactation
The goal of this study is to implement and evaluate the impact and cost effectiveness of a sero-discordant (male partner
HIV positive, female HIV negative) expecting couples HIV prevention program offering ART for male partners and pre-
exposure prophylaxis for expecting female partners implemented in Mozambique.
Role: Co-I

Graham (PI) 09/01/18-8/30/23 0.24 calendar

University of Washington $9,646 DC
Shikamana PrEP: A Community Participatory Approach to Integrating PrEP, Sexual Health, and Mental Health Services for
GBMSM in Kenya.
The goal of this study is to develop and implement a plot for community programs that promote comprehensive services
for MSM in Kenya.
Role: Co-I (Gary Harper leads this subcontract)

CLOSED/COMPELTED

5-U01-HD-040533-15 Wilson (PI) 03/01/17-10/31/17 0 calendar

University of Alabama at Birmingham $8,547 DC
Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN)
The goals of this project is to ensure that the Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN)
conducts youth-focused research that is innovative, significant, and feasible with maximum potential public health

5
impact for the target populations. The broad scientific research agenda encompasses primary, secondary, and tertiary
prevention of HIV among youth and includes testing strategies and approaches for HIV prevention, managing HIV in
youth, and enhancing life decisions and health outcomes in HIV-infected youth.
Role: Co-I

PrEP15160 Amico (PI) 09/01/15-12/31/17 0.60 calendar

Gilead $117,697 DC
Audio visual representation of PreExposure Prophylaxis (PrEP Rep): Adapting PrEP REP video to inform and educate cis
and transgender women about PrEP
The goals of this project are to develop two brief (5-7 minute) media clips using the original PrEP REP video as a starting
point specifically for PrEP education and literacy among cis women and transgender women; Evaluate immediate impact
of viewing the video on PrEP literacy among cis women (n=20) and transgender women (n=20); Make resulting videos
widely available and accessible to PrEP demonstration projects, open label PrEP studies, and physicians prescribing PrEP
or individuals considering PrEP in the US through easily accessed web venues (whatisprep.org).
Role: PI

3-P30-MH043520-28S1 Remien (PI) 02/01/16-01/31/18 0.60 calendar

Research Foundation for Mental Hygiene, Inc. $50,403 DC
HIV Center for Clinical and Behavioral Studies-Admin Supplement
The goal of this study is to identify and characterize facilitators and challenges to access and use of HIV prevention and
treatment services among HIV negative and positive heterosexual men and women and MSM (in and out of HIV care) in
fishing and non-fishing communities in Kenya through qualitative interviews and focus groups.
Role: Co-I

MAC AIDS FUND Amico (PI) 12/14/2014-12/13/2015

University of Michigan
Optimizing Linkage to Care for HIV+ MSM and Transgender Youth in Detroit Metro.
The goal of this study is to implement and evaluate a structured curriculum focused on best practice counseling and
motivation enhancement strategies with Early Intervention Specialists (EIS) in the City of Detroit’s Department of Health
and Wellness Promotion, in combination with a fully functional website portal of pertinent referrals and resources, on
linkage to care and positive evaluation of the curriculum and website portal of EIS.
Role: Co-I

FCO 104165/ID 0080.0256 Amico (PI) 12/1/2015-11/31/2016

FHI360/NIH-NIMH
HPTN 069: Pre-Exposure Prophylaxis (PrEP) to Prevent HIV Transmission in At-Risk Men Who Have Sex with Men
This study assesses the safety and tolerability of four antiretroviral (ARV) drug regimens used as pre-exposure
prophylaxis (PrEP) to prevent HIV transmission in a population of at-risk men who have sex with men (MSM).
Role: Co-I

U01 AI068619 El-Sadr (PI) 10/1/2011 – 11/30/2015

FHI360/NIH-NIMH
HPTN 067 Behavioral Aspects of PrEP Counseling for Intermittent Exposure
This study is designed to optimize and facilitate future efficacy research, to be proposed separately. The study aims to
identify dosing regimens that foster healthy sexual and pill-taking practices in people with the highest incidence of HIV-1
infection.
Role: Co-I

6
1R01MH095628-01 Liu (PI) 9/1/2011-6/30/2016
SFPH/NIH-NIMH
Enhancing PrEP adherence support and risk reduction in a public health setting
The goal of this study is to optimize support of MSM utilizing PrEP (oral pre-exposure prophylaxis) in diverse clinical and
community settings and reducing risk behaviors in a randomized clinical trial conducted at the municipal STD clinic in
San Francisco.
Role: Co-I

1R01MH095628-01 Liu (PI) 09/01/2011-06/30/2016

San Francisco Department of Public Health NIH/NIMH
Enhancing PrEP adherence support and risk reduction in a public health setting
The goal of this study is to optimize support of MSM utilizing PrEP (oral pre-exposure prophylaxis) in diverse clinical and
community settings and reducing risk behaviors in a randomized clinical trial conducted at the municipal STD clinic in
San Francisco.
Role: Co-I

Gilead Sciences Unrestricted Educational Grant #11672 (Amico PI) 12/15/2012-12/15/2013

Gilead Sciences
Audio visual representation of PreExposure Prophylaxis (PrEP Rep): Innovations for informing and motivating potential
and current PrEP users
A one year project that developed a media clip explaining the mechanisms of PrEP and depiction of actions of adherence
and non-adherence. Project included assessment of immediate impact on information and attitudes among a group of
PrEP experiences MSM and PrEP naïve MSM.
Role: PI

R01 MH077524-04 (Fisher, J.D.) 01/11/2007 - 12/31/2012

University of Connecticut NIH/NIMH
Integrating HIV Prevention into Clinical Care for PLWHA in South Africa
The primary goal of this project is to design, implement, and evaluate a theory-based HIV risk reduction intervention for
HIV-infected clients that are implemented in clinical care settings in South Africa by lay counselors.
Role: Collaborator, intervention development, statistical analyst

Ann Ferris (UCHC PI), K. Rivet Amico (Uconn PI) 07/01/2011-12/31/2011

University of Connecticut USDA
Effectiveness of an IBM-Based Intervention for Reducing Sweetened Beverage Consumption in Preschool Children
The major goal is to evaluate the effectiveness of an Information-Motivation-Behavioral Skills Model (IMB) -based
intervention aimed at reducing calories consumed from sweetened beverage and 100% fruit juice (SB/FJC) in
preschoolers using parents as agents of change.
Role: Co-I

3R01 MH077524-04S1 Fisher, J.D. (PI) 09/29/2010 - 12/31/2011

University of Connecticut NIH/NIMH
Supplement to: Integrating HIV prevention into clinical care for South African PLWHA
The primary goal of this project is to implement a behaviorally- and biologically-focused HIV prevention initiative
targeted specifically toward this critical population of PLWH. Our implementation science-informed, adapted version of
the Options for Health intervention for newly diagnosed PLWH not yet on ART aims to engage these individuals in care

7
at the earliest possible point, reduce HIV transmission risk behavior, and provide these newly diagnosed individuals with
health maintenance support.
Role: Co-I

5R34MH084670-02 Konkle-Parker (PI) 09/08/2008-08/31/2011

University of Mississippi, NIH/NIMH
Multidimensional HIV Treatment Adherence Intervention
This study expands the concept of adherence to include adherence to clinical care, and focuses on an understudied
population, that of HIV-infected individuals residing in the Deep South. The project will develop and pilot an MI-, IMB-
model based, individually tailored and culturally grounded intervention to promote adherence to both HIV-medication
requirements and to current recommendations for consistent use of HIV-care clinical services.
Role: Co-I

1 R01 MH066684-01A1 Jeffrey D. Fisher, Ph.D. (PI) 09/19/2006-06/30/2009

University of Connecticut NIMH
Changing ART Adherence Behavior
The major goals of this project are to design, implement, and evaluate a theory-based, computer-assisted ART
adherence intervention for a clinical care population.
Role: Co-PI, Data manager and analyst

Gerald Friedland (YALE PI), K. Rivet Amico (UConn PI) 04/14/2008-04/13/2009

Yale University Abbott Pharmaceutical
Antiretroviral Adherence and HIV Drug Resistance Outcomes in Clinical Care
Collection of medical record data for LifeWindows enrolled participants of all resistance testing and results. Evaluate role
of resistance in treatment response, the adherence-clinical outcome relationship, and its natural variability over time.
Role: Data manager and analyst.

TEACHING AND MENTORSHIP

COURSES
HBHE 621 (Winter/Spring 2015, 2016, 2017)- Advanced Research Methods -- Seminar in Behavioral Research Methods
in Public Health
The purpose of this course is to provide practical advice on how to conduct studies that employ survey research
methodology. I kept one basic question in mind as I developed the course: What aren't you told in graduate school that
you really need to know once you're out in the field? As a result, the course is not designed to be self-contained.
Instead, it should be viewed as a supplement to other research methods courses in the School of Public Health.

HBHE550 (Fall 2015) - HIV/AIDS: Perspectives on the state of affairs, science and response to a global pandemic.
About 35 million people are currently living with HIV, with 71% living in sub-Saharan Africa. For the first time, new
treatments and strategies to prevent onward transmission have brought a vision of an “AIDS free generation”. The
influence of research, dissemination, policy and advocacy underlie US and International HIV/AIDS Strategies, which are
uniformly adopting aggressive goals for eliminating new cases of HIV in the next decade. From the “cascade of HIV care”
a new road map towards prevention and treatment has emerged and the role of individual health promotion,
community engagement, health systems reforms, and policy are pivotal in achieving sustainable success in ending HIV.
This course provides an overview of past, current and emerging issues in HIV-prevention, HIV testing, linkage and
retention in HIV care, access to HIV treatment and achieving durable viral suppression in diverse domestic and global
contexts from biological, social, structural, cultural and psychological perspectives.

8
MENTEES (Current)
• Latesha Elopre, MD, University of Alabama Birmingham, K23 (co-mentor)
• Greer Burkholder, MD, University of Alabama Birmingham, K23 (co-mentor)
• Carolyn Audet, PhD, Vanderbilt University, K01 (co-primary mentor)
• Bich Ngoc Dang, MD, Baylor College of Medicine, K23 (co-mentor)
• Charlene Flash, MD MPH, Baylor College of Medicine, K23 (co-mentor)
• Mercy Mutambanengwe, MA, University of Zimbabwe, College of Health Sciences, School of Pharmacy,
President’s Emergency Plan for AIDS Relief (PEPFAR) through the PEPFAR-PROMOTE Study Research and
Mentorship Programme. (co-supervisor)
HBHE MENTEES (2017-2018)
• Hannah Brady, Jessica Milne, Daniel Bohn (HBHE MPH candidates), research supervisor.
• Sarah Gutin (HBHE Doctoral candidates), dissertation committee member.

PEER REVIEWED PUBLICATIONS (since 2004)

1. Modi R, Amico KR, Knudson A, Westfall AO, Keruly J, Crane HM, et al. Assessing effects of behavioral
intervention on treatment outcomes among patients initiating HIV care: Rationale and design of iENGAGE
intervention trial. Contemporary clinical trials. 2018 Mar 8;69:48-54.
2. Bionghi N, Daftary A, Maharaj B, Msibi Z, Amico KR, Friedland G, et al. Pilot evaluation of a second-generation
electronic pill box for adherence to Bedaquiline and antiretroviral therapy in drug-resistant TB/HIV co-infected
patients in KwaZulu-Natal, South Africa. BMC infectious diseases. 2018 Apr 11;18(1):171.
3. Chiang N, Guo M, Amico KR, Atkins L, Lester RT. Interactive Two-Way mHealth Interventions for Improving
Medication Adherence: An Evaluation Using The Behaviour Change Wheel Framework. JMIR Mhealth Uhealth.
2018;6(4).
4. Hojilla JC, Mehrotra M, Truong HM, Glidden DV, Amico KR, McMahan V, et al. HIV sero disclosure among men
who have sex with men and transgender women on HIV pre-exposure prophylaxis. AIDS care. 2018;30(4):466-
72.
5. Flash CA, Frost ELT, Giordano TP, Amico KR, Cully JA, Markham CM. HIV Pre-exposure Prophylaxis Program
Implementation Using Intervention Mapping. Am J Prev Med. 2018 Feb 9. [Epub ahead of print] PubMed PMID:
29433956.
6. Mitchell KM, Dimitrov D, Hughes JP, Xia F, Donnell D, Amico KR, Bokoch K, Chitwarakorn A, Bekker LG, Holtz TH,
Mannheimer S, Grant RM, Boily MC. In what circumstances could nondaily preexposure prophylaxis for HIV
substantially reduce program costs? AIDS. 2018 Feb 8. [Epub ahead of print] PubMed PMID: 29424774.
7. Franks J, Hirsch-Moverman Y, Loquere AS Jr, Amico KR, Grant RM, Dye BJ, Rivera Y, Gamboa R, Mannheimer SB.
Sex, PrEP, and Stigma: Experiences with HIV Pre-exposure Prophylaxis Among New York City MSM Participating
in the HPTN 067/ADAPT Study. AIDS Behav. 2017 Nov 15. [Epub ahead of print] PubMed PMID: 29143163.
8. Riddell J, Amico KR, Mayer KH. HIV Preexposure Prophylaxis: A Review. Jama. 2018;319(12):1261-8.
9. Zelnick JR, Seepamore B, Daftary A, Amico KR, Bhengu X, Friedland G, et al. Training social workers to enhance
patient-centered care for drug-resistant TB-HIV in South Africa. Public Health Action. 2018;8(1):25-7.
10. Fuchs JD, Stojanovski K, Vittinghoff E, McMahan VM, Hosek SG, Amico KR, et al. A Mobile Health Strategy to
Support Adherence to Antiretroviral Preexposure Prophylaxis. AIDS patient care and STDs. 2018;32(3):104-11.
11. Hojilla JC, Vlahov D, Glidden DV, Amico KR, Mehrotra M, Hance R, et al. Skating on thin ice: stimulant use and
sub-optimal adherence to HIV pre-exposure prophylaxis. Journal of the International AIDS Society.
2018;21(3):25103.

9
12. Grant RM, Mannheimer S, Hughes JP, Hirsch-Moverman Y, Loquere A, Chitwarakorn A, Curlin ME, Li M, Amico
KR, Hendrix CW, Anderson PL, Dye BJ, Marzinke MA, Piwowar-Manning E, McKinstry L, Elharrar V, Stirratt M,
Rooney JF, Eshleman SH, McNicholl JM, van Griensven F, Holtz TH. Daily and Nondaily Oral Preexposure
Prophylaxis in Men and Transgender Women Who Have Sex With Men: The Human Immunodeficiency Virus
Prevention Trials Network 067/ADAPT Study. Clin Infect Dis. 2018 Feb 6. [Epub ahead of print] PubMed PMID:
29420695.
13. Smith LR, Amico KR, Fisher JD, Cunningham CO. 60 Minutes for health: examining the feasibility and
acceptability of a low-resource behavioral intervention designed to promote retention in HIV care. AIDS care.
2018 Feb;30(2):255-265. doi: 10.1080/09540121.2017.1344184. Epub 2017 Jun 28. PubMed PMID: 28657333.
14. Amico KR, Mugavero M, Krousel-Wood MA, Bosworth HB, Merlin JS. Advantages to Using Social-Behavioral
Models of Medication Adherence in Research and Practice. Journal of general internal medicine. 2017 Dec 4.
15. Bekker LG, Roux S, Sebastien E, Yola N, Amico KR, Hughes JP, et al. Daily and non-daily pre-exposure prophylaxis
in African women (HPTN 067/ADAPT Cape Town Trial): a randomised, open-label, phase 2 trial. The lancet HIV.
2018 Feb;5(2):e68-e78.
16. Liu Y, Vermund SH, Ruan Y, Liu H, Rivet Amico K, Simoni JM, et al. Peer counselling versus standard-of-care on
reducing high-risk behaviours among newly diagnosed HIV-positive men who have sex with men in Beijing,
China: a randomized intervention study. Journal of the International AIDS Society. 2018;21(2):25079.
17. Uuskula A, Laisaar KT, Raag M, Lemsalu L, Lohmus L, Ruutel K, [Amico KR LA] et al. Effects of Counselling on
Adherence to Antiretroviral Treatment Among People with HIV in Estonia: A Randomized Controlled Trial. AIDS
and behavior. 2018 Jan;22(1):224-233. doi: 10.1007/s10461-017-1859-6. PubMed PMID: 28717981.
18. Chapman Lambert C, Marrazzo J, Amico KR, Mugavero MJ, Elopre L. PrEParing Women to Prevent HIV: An
Integrated Theoretical Framework to PrEP Black Women in the United States. The Journal of the Association of
Nurses in AIDS Care : JANAC. 2018;5(18):30073-6.
19. Landovitz RJ, Beymer M, Kofron R, Amico KR, Psaros C, Bushman L, et al. Plasma Tenofovir-levels to Support
Adherence to TDF/FTC Pre-exposure Prophylaxis for HIV Prevention in MSM in Los Angeles, California. J Acquir
Immune Defic Syndr. 2017 Dec 15;76(5):501-511. PubMed PMID: 28902074; PubMed Central PMCID:
PMC5681370.
20. Chang LW, Mbabali I, Kong X, Hutton H, Amico KR, Kennedy CE, et al. Impact of a community health worker HIV
treatment and prevention intervention in an HIV hotspot fishing community in Rakai, Uganda (mLAKE): study
protocol for a randomized controlled trial. Trials. 2017;18(1):494. PMID: 29061194; PubMed Central PMCID:
PMC5654192.
21. Gulick RM, Wilkin TJ, Chen YQ, Landovitz RJ, Amico KR, Young AM, et al. Safety and Tolerability of Maraviroc-
Containing Regimens to Prevent HIV Infection in Women: A Phase 2 Randomized Trial. Annals of internal
medicine. 2017 Sep 19;167(6):384-393. doi: 10.7326/M17-0520. Epub 2017 Aug 22. PubMed PMID: 28828489;
PubMed Central PMCID: PMC5667908.
22. Long A, Mbabali I, Hutton HE, Thomas AG, Bugos E, Mulamba J, Amico KR, et al. Design and Implementation of a
Community Health Worker HIV Treatment and Prevention Intervention in an HIV Hot Spot Fishing Community in
Rakai, Uganda. Journal of the International Association of Providers of AIDS Care. 2017;16(5):499-505.
23. Gutin SA, Amico KR, Hunguana E, Munguambe AO, Rose CD. The Relationship of Repeated Technical Assistance
Support Visits to the Delivery of Positive Health, Dignity, and Prevention (PHDP) Messages by Healthcare
Providers in Mozambique: A Longitudinal Multilevel Analysis. Journal of the International Association of

10
 Providers of AIDS Care. 2017 Sep/Oct;16(5):487-493. doi: 10.1177/2325957417724206. Epub 2017 Aug 10.
PubMed PMID: 28795611.
24. Bendetson J, Dierst-Davies R, Flynn R, Beymer MR, Wohl AR, Amico KR, et al. Evaluation of a Client-Centered
Linkage Intervention for Patients Newly Diagnosed with HIV at an Urban United States LGBT Center: The Linkage
to Care Specialist Project. AIDS patient care and STDs. 2017;31(7):283-9.
25. Modi RA, Mugavero MJ, Amico RK, Keruly J, Quinlivan EB, Crane HM, Guzman A, Zinski A, Montue S, Roytburd K,
Church A, Willig JH. A Web-Based Data Collection Platform for Multisite Randomized Behavioral Intervention
Trials: Development, Key Software Features, and Results of a User Survey. JMIR Res Protoc. 2017 Jun
16;6(6):e115. doi: 10.2196/resprot.6768. PubMed PMID: 28623185; PubMed Central PMCID: PMC5493783.
26. Koester K, Amico RK, Gilmore H, Liu A, McMahan V, Mayer K, Hosek S, Grant R. Risk, safety and sex among male
PrEP users: time for a new understanding. Cult Health Sex. 2017 Dec;19(12):1301-1313. doi:
10.1080/13691058.2017.1310927. Epub 2017 Apr 18. PubMed PMID: 28415911.
27. Sivay MV, Li M, Piwowar-Manning E, Zhang Y, Hudelson SE, Marzinke MA, Amico RK, Redd A, Hendrix CW,
Anderson PL, Bokoch K, Bekker LG, van Griensven F, Mannheimer S, Hughes JP, Grant R, Eshleman SH; HPTN
067/ADAPT Study Team. Characterization of HIV Seroconverters in a TDF/FTC PrEP Study: HPTN 067/ADAPT. J
Acquir Immune Defic Syndr. 2017 Jul 1;75(3):271-279. doi:10.1097/QAI.0000000000001374. PubMed PMID:
28328548; PubMed Central PMCID: PMC5472493.
28. Liu Y, Qian HZ, Amico KR, Liu H, Yin L, Ruan Y, Shao Y, Zhang C, Vermund SH. Subsequent Sexual Risks Among
Men Who Have Sex with Men May Differ by Sex of First Partner and Age at Sexual Debut: A Cross-Sectional
Study in Beijing, China.AIDS Behav. 2017 Oct;21(10):2913-2923. doi: 10.1007/s10461-017-1677-x. PubMed
PMID: 28110474; PubMed Central PMCID: PMC5522364.
29. Amico KR, Wallace M, Bekker LG, et al. Experiences with HPTN 067/ADAPT Study-Provided Open-Label PrEP
Among Women in Cape Town: Facilitators and Barriers Within a Mutuality Framework. AIDS and behavior. May
2017;21(5):1361-1375.
30. Audet CM, Salato J, Vermund SH, Amico KR. Adapting an adherence support workers intervention: engaging
traditional healers as adherence partners for persons enrolled in HIV care and treatment in rural Mozambique.
Implementation science: IS. Apr 13 2017;12(1):50. PubMed PMID: 28407813; PubMed Central PMCID:
PMC5390357.
31. Haberer JE, Sabin L, Amico KR, et al. Improving antiretroviral therapy adherence in resource-limited settings at
scale: a discussion of interventions and recommendations. Journal of the International AIDS Society. Mar 22
2017;20(1):1-15. PubMed PMID: 28630651; PubMed Central PMCID: PMC5467606
32. Davila JA, Hartman C, Cully J, Stanley M, Amico KR, et al. Feasibility of identifying out of care HIV-positive
patients in a hospital setting and enrolling them in a retention intervention. HIV clinical trials. Mar
2017;18(2):75-82. https://www.ncbi.nlm.nih.gov/pubmed/28212601 PubMed PMID: 28212601; PubMed
Central PMCID: PMC5611820.
33. Tao J, Vermund SH, Lu H, Ruan Y, Shepherd BE, Kipp AM, Amico KR, et al. Impact of Depression and Anxiety on
Initiation of Antiretroviral Therapy Among Men Who Have Sex with Men with Newly Diagnosed HIV Infections in
China. AIDS patient care and STDs. Feb 2017;31(2):96-104. PubMed PMID: 28170305; PubMed Central PMCID:
PMC5312604.
34. Tao J, Qian HZ, Kipp AM, Ruan Y, Shepherd BE, Amico KR et al. Effects of depression and anxiety on antiretroviral
therapy adherence among newly diagnosed HIV-infected Chinese MSM. AIDS (London, England). Jan 28
2017;31(3):401-406. PubMed PMID: 27677168; PubMed Central PMCID: PMC5233466.
35. Gulick RM, Wilkin TJ, Chen YQ, Landovitz RJ, Amico KR, et al. Phase 2 Study of the Safety and Tolerability of
Maraviroc-Containing Regimens to Prevent HIV Infection in Men Who Have Sex With Men (HPTN 069/ACTG

11
 A5305). The Journal of infectious diseases. Jan 15 2017;215(2):238-246. PubMed PMID: 27811319; PubMed
Central PMCID: PMC5790146.https://www.ncbi.nlm.nih.gov/pubmed/27811319
36. Liu Y, Ruan Y, Strauss SM, Yin L, Liu H, Amico KR, et al. Alcohol misuse, risky behaviors, and HIV or syphilis
infections among Chinese men who have sex with men. Drug Alcohol Depend. 2016, 168: 239-246.
37. Tangmunkongvorakul A, Chariyalertsak S, Amico KR, Guptarak M, Saokhieo P, Sangangamsakun T, et al. Sexual
practives among men who have sex with men in Chiang Mai, Thailand. Southeast Asian J Trop Med Public Health
2016,47:514-527.
38. Shaw S, Amico KR. Antiretroviral Therapy Adherence Enhancing Interventions for Adolescents and Young Adults
13-24 Years of Age: A Review of the Evidence Base. J Acquir Immune Defic Syndr 2016,72:387-399.
39. O'Donnell MR, Daftary A, Frick M, Hirsch-Moverman Y, Amico KR, Senthilingam M, et al. Re-inventing
adherence: toward a patient-centered model of care for drug-resistant tuberculosis and HIV. Int J Tuberc Lung
Dis 2016,20:430-434.
40. Norwood MS, Hughes JP, Amico KR. The validity of self-reported behaviors: methods for estimating
underreporting of risk behaviors. Ann Epidemiol 2016,26:612-618.e612.
41. Mehrotra ML, Glidden DV, McMahan V, Amico KR, Hosek S, Defechereux P, et al. The Effect of Depressive
Symptoms on Adherence to Daily Oral PrEP in Men who have Sex with Men and Transgender Women: A
Marginal Structural Model Analysis of The iPrEx OLE Study. AIDS Behav 2016,20:1527-1534.
42. Liu Y, Osborn CY, Qian HZ, Yin L, Xiao D, Ruan Y, et al. [Amico last author] Barriers and Facilitators of Linkage to
and Engagement in HIV Care Among HIV-Positive Men Who Have Sex with Men in China: A Qualitative Study.
AIDS Patient Care STDS 2016,30:70-77.
43. Liu Y, Li D, Vermund SH, Zhang C, Ruan Y, Yin L, et al. Associations of current marital status and living
arrangements with HIV and syphilis risk: findings from a community-based sample of men who have sex with
men in China. AIDS Care 2016,28:1461-1466.
44. Liu AY, Cohen SE, Vittinghoff E, Anderson PL, Doblecki-Lewis S, Bacon O, et al. Preexposure Prophylaxis for HIV
Infection Integrated With Municipal- and Community-Based Sexual Health Services. JAMA Intern Med
2016,176:75-84.
45. Hoenigl M, Chaillon A, Moore DJ, et al. Rapid HIV Viral Load Suppression in those Initiating Antiretroviral Therapy
at First Visit after HIV Diagnosis. Scientific reports. Sep 06 2016;6:32947.
46. Glidden DV, Amico KR, Liu AY, Hosek SG, Anderson PL, Buchbinder SP, et al. Symptoms, Side Effects and
Adherence in the iPrEx Open-Label Extension. Clin Infect Dis 2016,62:1172-1177.
47. Giordano TP, Cully J, Amico KR, Davila JA, Kallen MA, Hartman C, et al. A Randomized Trial to Test a Peer Mentor
Intervention to Improve Outcomes in Persons Hospitalized With HIV Infection. Clin Infect Dis 2016,63:678-686.
48. Defechereux PA, Mehrotra M, Liu AY, McMahan VM, Glidden DV, Mayer KH, et al. Depression and Oral FTC/TDF
Pre-exposure Prophylaxis (PrEP) Among Men and Transgender Women Who Have Sex With Men (MSM/TGW).
AIDS Behav 2016,20:1478-1488.
49. Audet CM, Chire YM, Vaz LM, Bechtel R, Carlson-Bremer D, Wester CW, et al. Barriers to Male Involvement in
Antenatal Care in Rural Mozambique. Qual Health Res 2016,26:1721-1731.
50. Amico KR, Mehrotra M, Avelino-Silva VI, McMahan V, Veloso VG, Anderson P, et al. Self-reported Recent PrEP
Dosing and Drug Detection in an Open Label PrEP Study. AIDS Behav 2016,20:1535-1540.
51. van der Straten A, Mayo A, Brown ER, Amico KR, Cheng H, Laborde N, et al. Perceptions and Experiences with
the VOICE Adherence Strengthening Program (VASP) in the MTN-003 Trial. AIDS Behav 2015,19:770-783.
52. Liu Y, Sun X, Qian HZ, Yin L, Yan Z, Wang L, et al. [Amico last author] Qualitative Assessment of Barriers and
Facilitators of Access to HIV Testing Among Men Who Have Sex with Men in China. AIDS Patient Care STDS
2015,29:481-489.
53. Lippman SA, Koester KA, Amico KR, Lama JR, Martinez Fernandes N, Gonzales P, et al. Client and provider
perspectives on new HIV prevention tools for MSM in the Americas. PLoS One 2015,10:e0121044.

12
54. Koester KA, Liu A, Eden C, Amico KR, McMahan V, Goicochea P, et al. Acceptability of drug detection monitoring
among participants in an open-label pre-exposure prophylaxis study. AIDS Care 2015,27:1199-1204.
55. Haberer JE, Bangsberg DR, Baeten JM, Curran K, Koechlin F, Amico KR, et al. Defining success with HIV pre-
exposure prophylaxis: a prevention-effective adherence paradigm. Aids 2015,29:1277-1285.
56. Amico KR. Evidence for Technology Interventions to Promote ART Adherence in Adult Populations: a Review of
the Literature 2012-2015. Curr HIV/AIDS Rep 2015,12:441-450.
57. Ye S, Yin L, Amico R, Simoni J, Vermund S, Ruan Y, et al. Efficacy of peer-led interventions to reduce unprotected
anal intercourse among men who have sex with men: a meta-analysis. PLoS One 2014,9:e90788.
58. Mills EJ, Lester R, Thorlund K, Lorenzi M, Muldoon K, Kanters S, et al. Interventions to promote adherence to
antiretroviral therapy in Africa: a network meta-analysis. Lancet HIV 2014,1:e104-111.
59. Marcus JL, Buisker T, Horvath T, Amico KR, Fuchs JD, Buchbinder SP, et al. Helping our patients take HIV pre-
exposure prophylaxis (PrEP): a systematic review of adherence interventions. HIV Med 2014,15:385-395.
60. Mansoor LE, Karim QA, Werner L, Madlala B, Ngcobo N, Cornman DH, et al. Impact of an adherence intervention
on the effectiveness of tenofovir gel in the CAPRISA 004 trial. AIDS Behav 2014,18:841-848.
61. MacQueen KM, Tolley EE, Owen DH, Amico KR, Morrow KM, Moench T, et al. An interdisciplinary framework for
measuring and supporting adherence in HIV prevention trials of ARV-based vaginal rings. J Int AIDS Soc
2014,17:19158.
62. Liu AY, Hessol NA, Vittinghoff E, Amico KR, Kroboth E, Fuchs J, et al. Medication adherence among men who
have sex with men at risk for HIV infection in the United States: implications for pre-exposure prophylaxis
implementation. AIDS Patient Care STDS 2014,28:622-627.
63. Liu A, Glidden DV, Anderson PL, Amico KR, McMahan V, Mehrotra M, et al. Patterns and correlates of PrEP drug
detection among MSM and transgender women in the Global iPrEx Study. J Acquir Immune Defic Syndr
2014,67:528-537.
64. Konkle-Parker DJ, Amico KR, McKinney VE. Effects of an intervention addressing information, motivation, and
behavioral skills on HIV care adherence in a southern clinic cohort. AIDS Care 2014,26:674-683.
65. Horvath KJ, Smolenski D, Amico KR. An empirical test of the information-motivation-behavioral skills model of
ART adherence in a sample of HIV-positive persons primarily in out-of-HIV-care settings. AIDS Care 2014,26:142-
151.
66. Grant RM, Anderson PL, McMahan V, Liu A, Amico KR, Mehrotra M, et al. Uptake of pre-exposure prophylaxis,
sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study.
Lancet Infect Dis 2014,14:820-829.
67. Fisher JD, Cornman DH, Shuper PA, Christie S, Pillay S, Macdonald S, et al. HIV prevention counseling
intervention delivered during routine clinical care reduces HIV risk behavior in HIV-infected South Africans
receiving antiretroviral therapy: the Izindlela Zokuphila/Options for Health randomized trial. J Acquir Immune
Defic Syndr 2014,67:499-507.
68. de Bruin M, Simoni J, Amico KR, Parsons JT, Fisher J, Safren SA. Poor citation, coding and reporting: a review of
adherence-enhancing interventions for highly active antiretroviral therapy creates an inaccurate picture of the
state of the field. HIV Med 2014,15:381-382.
69. Amico KR, Stirratt MJ. Adherence to preexposure prophylaxis: current, emerging, and anticipated bases of
evidence. Clin Infect Dis 2014,59 Suppl 1:S55-60.
70. Amico KR, Marcus JL, McMahan V, Liu A, Koester KA, Goicochea P, et al. Study product adherence measurement
in the iPrEx placebo-controlled trial: concordance with drug detection. J Acquir Immune Defic Syndr
2014,66:530-537.
71. Amico KR. The key role of adherence for the effectiveness of antiretroviral-based prevention: state of the
science and implications for the Asia-Pacific region. Sex Health 2014,11:155-165.
72. Woodsong C, MacQueen K, Amico KR, Friedland B, Gafos M, Mansoor L, et al. Microbicide clinical trial
adherence: insights for introduction. J Int AIDS Soc 2013,16:18505.

13
73. Williams AB, Amico KR, Bova C, Womack JA. A proposal for quality standards for measuring medication
adherence in research. AIDS Behav 2013,17:284-297.
74. Tangmunkongvorakul A, Chariyalertsak S, Amico KR, Saokhieo P, Wannalak V, Sangangamsakun T, et al.
Facilitators and barriers to medication adherence in an HIV prevention study among men who have sex with
men in the iPrEx study in Chiang Mai, Thailand. AIDS Care 2013,25:961-967.
75. Smith LR, Amico KR, Shuper PA, Christie S, Fisher WA, Cornman DH, et al. Information, motivation, and
behavioral skills for early pre-ART engagement in HIV care among patients entering clinical care in KwaZulu-
Natal, South Africa. AIDS Care 2013,25:1485-1490.
76. Mugavero MJ, Amico KR, Horn T, Thompson MA. The state of engagement in HIV care in the United States: from
cascade to continuum to control. Clin Infect Dis 2013,57:1164-1171.
77. Mayer K, Gazzard B, Zuniga JM, Amico KR, Anderson J, Azad Y, et al. Controlling the HIV epidemic with
antiretrovirals: IAPAC consensus statement on treatment as prevention and preexposure prophylaxis. J Int Assoc
Provid AIDS Care 2013,12:208-216.
78. Marcus JL, Glidden DV, Mayer KH, Liu AY, Buchbinder SP, Amico KR, et al. No evidence of sexual risk
compensation in the iPrEx trial of daily oral HIV preexposure prophylaxis. PLoS One 2013,8:e81997.
79. Laisaar KT, Uuskula A, Sharma A, DeHovitz JA, Amico KR. Developing an adherence support intervention for
patients on antiretroviral therapy in the context of the recent IDU-driven HIV/AIDS epidemic in Estonia. AIDS
Care 2013,25:863-873.
80. Horvath KJ, Oakes JM, Rosser BR, Danilenko G, Vezina H, Amico KR, et al. Feasibility, acceptability and
preliminary efficacy of an online peer-to-peer social support ART adherence intervention. AIDS Behav
2013,17:2031-2044.
81. Horvath KJ, Carrico AW, Simoni J, Boyer EW, Amico KR, Petroll AE. Engagement in HIV Medical Care and
Technology Use among Stimulant-Using and Nonstimulant-Using Men who have Sex with Men. AIDS Res Treat
2013,2013:121352.
82. Gilmore HJ, Liu A, Koester KA, Amico KR, McMahan V, Goicochea P, et al. Participant experiences and facilitators
and barriers to pill use among men who have sex with men in the iPrEx pre-exposure prophylaxis trial in San
Francisco. AIDS Patient Care STDS 2013,27:560-566.
83. Earnshaw VA, Smith LR, Chaudoir SR, Amico KR, Copenhaver MM. HIV stigma mechanisms and well-being among
PLWH: a test of the HIV stigma framework. AIDS Behav 2013,17:1785-1795.
84. Amico KR, Zuniga JM, Wilson IB, Gross R, Young B. Provider guidance for linking patients to antiretroviral
therapy adherence interventions: recommendations from an IAPAC advisory committee on adherence
monitoring and support. J Int Assoc Provid AIDS Care 2013,12:79-83.
85. Amico KR, Orrell C. Antiretroviral therapy adherence support: recommendations and future directions. J Int
Assoc Provid AIDS Care 2013,12:128-137.
86. Amico KR, Mansoor LE, Corneli A, Torjesen K, van der Straten A. Adherence support approaches in biomedical
HIV prevention trials: experiences, insights and future directions from four multisite prevention trials. AIDS
Behav 2013,17:2143-2155.
87. Uuskula A, Laisaar KT, Raag M, Smidt J, Semjonova S, Kogan J, et al. Antiretroviral therapy (ART) adherence and
correlates to nonadherence among people on ART in Estonia. AIDS Care 2012,24:1470-1479.
88. Thompson MA, Mugavero MJ, Amico KR, Cargill VA, Chang LW, Gross R, et al. Guidelines for improving entry into
and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from
an International Association of Physicians in AIDS Care panel. Ann Intern Med 2012,156:817-833, w-284, w-285,
w-286, w-287, w-288, w-289, w-290, w-291, w-292, w-293, w-294.
89. Smith LR, Fisher JD, Cunningham CO, Amico KR. Understanding the behavioral determinants of retention in HIV
care: a qualitative evaluation of a situated information, motivation, behavioral skills model of care initiation and
maintenance. AIDS Patient Care STDS 2012,26:344-355.

14
90. Norton WE, Fisher JD, Amico KR, Dovidio JF, Johnson BT. Relative efficacy of a pregnancy, sexually transmitted
infection, or human immunodeficiency virus prevention-focused intervention on changing sexual risk behavior
among young adults. J Am Coll Health 2012,60:574-582
91. Mugavero MJ, Amico KR, Westfall AO, Crane HM, Zinski A, Willig JH, et al. Early retention in HIV care and viral
load suppression: implications for a test and treat approach to HIV prevention. J Acquir Immune Defic Syndr
2012,59:86-93.
92. Kanjee Z, Amico KR, Li F, Mbolekwa K, Moll AP, Friedland GH. Tuberculosis infection control in a high drug-
resistance setting in rural South Africa: information, motivation, and behavioral skills. J Infect Public Health
2012,5:67-81.
93. Horvath KJ, Danilenko GP, Williams ML, Simoni J, Amico KR, Oakes JM, et al. Technology use and reasons to
participate in social networking health websites among people living with HIV in the US. AIDS Behav
2012,16:900-910.
94. Goodell LS, Pierce MB, Amico KR, Ferris AM. Parental information, motivation, and behavioral skills correlate
with child sweetened beverage consumption. J Nutr Educ Behav 2012,44:240-245.
95. Cully JA, Mignogna J, Stanley MA, Davila J, Wear J, Amico KR, et al. Development and pilot testing of a
standardized training program for a patient-mentoring intervention to increase adherence to outpatient HIV
care. AIDS Patient Care STDS 2012,26:165-172.
96. Catz SL, Thibodeau L, BlueSpruce J, Yard SS, Seal DW, Amico KR, et al. Prevention needs of HIV-positive men and
women awaiting release from prison. AIDS Behav 2012,16:108-120.
97. Amico KR. Adherence to preexposure chemoprophylaxis: the behavioral bridge from efficacy to effectiveness.
Curr Opin HIV AIDS 2012,7:542-548.
98. Amico KR, McMahan V, Goicochea P, Vargas L, Marcus JL, Grant RM, et al. Supporting study product use and
accuracy in self-report in the iPrEx study: next step counseling and neutral assessment. AIDS Behav
2012,16:1243-1259.
99. Williams B, Amico KR, Konkle-Parker D. Qualitative to assessment of barriers and facilitators to HIV treatment. J
Assoc Nurses AIDS Care 2011,22:307-312.
100. Osborn CY, Amico KR, Cruz N, Perez-Escamilla R, Kalichman SC, O'Connell AA, et al. Development and
Implementation of a Culturally Tailored Diabetes Intervention in Primary Care. Transl Behav Med 2011,1:568-
479.
101. Konkle-Parker DJ, Amico KR, Henderson HM. Barriers and facilitators to engagement in HIV clinical care
in the Deep South: results from semi-structured patient interviews. J Assoc Nurses AIDS Care 2011,22:90-99.
102. Kanjee Z, Catterick K, Moll AP, Amico KR, Friedland GH. Tuberculosis infection control in rural South
Africa: survey of knowledge, attitude and practice in hospital staff. J Hosp Infect 2011,79:333-338.
103. Fisher JD, Amico KR, Fisher WA, Cornman DH, Shuper PA, Trayling C, et al. Computer-based intervention
in HIV clinical care setting improves antiretroviral adherence: the LifeWindows Project. AIDS Behav
2011,15:1635-1646.
104. Ferrer RA, Fisher JD, Buck R, Amico KR. Pilot test of an emotional education intervention component for
sexual risk reduction. Health Psychol 2011,30:656-660.
105. Cornman DH, Christie S, Shepherd LM, MacDonald S, Amico KR, Smith LR, et al. Counsellor-delivered HIV
risk reduction intervention addresses safer sex barriers of people living with HIV in KwaZulu-Natal, South Africa.
Psychol Health 2011,26:1623-1641.
106. Amico KR. Standard of Care for Antiretroviral Therapy Adherence and Retention in Care from the
Perspective of Care Providers Attending the 5th International Conference on HIV Treatment Adherence. J Int
Assoc Physicians AIDS Care (Chic) 2011,10:291-296.
107. Simoni JM, Amico KR, Smith L, Nelson K. Antiretroviral adherence interventions: translating research
findings to the real world clinic. Curr HIV/AIDS Rep 2010,7:44-51.

15
 108. Osborn CY, Amico KR, Cruz N, O'Connell AA, Perez-Escamilla R, Kalichman SC, et al. A brief culturally
tailored intervention for Puerto Ricans with type 2 diabetes. Health Educ Behav 2010,37:849-862.
109. Norton WE, Amico KR, Fisher WA, Shuper PA, Ferrer RA, Cornman DH, et al. Information-motivation-
behavioral skills barriers associated with intentional versus unintentional ARV non-adherence behavior among
HIV+ patients in clinical care. AIDS Care 2010,22:979-987.
110. Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al. Preexposure chemoprophylaxis for
HIV prevention in men who have sex with men. N Engl J Med 2010,363:2587-2599.
111. Norton WE, Amico KR, Cornman DH, Fisher WA, Fisher JD. An agenda for advancing the science of
implementation of evidence-based HIV prevention interventions. AIDS Behav 2009,13:424-429.
112. Harman JJ, Amico KR. The relationship-oriented information-motivation-behavioral skills model: a
multilevel structural equation model among dyads. AIDS Behav 2009,13:173-184.
113. Ferrer RA, Amico KR, Bryan A, Fisher WA, Cornman DH, Kiene SM, et al. Accuracy of the stages of change
algorithm: sexual risk reported in the maintenance stage of change. Prev Sci 2009,10:13-21.
114. Amico KR, Barta W, Konkle-Parker DJ, Fisher JD, Cornman DH, Shuper PA, et al. The information-
motivation-behavioral skills model of ART adherence in a Deep South HIV+ clinic sample. AIDS Behav
2009,13:66-75.
115. Amico KR. Percent total attrition: a poor metric for study rigor in hosted intervention designs. Am J
Public Health 2009,99:1567-1575.
116. Simoni JM, Amico KR, Pearson CR, Malow R. Strategies for promoting adherence to antiretroviral
therapy: a review of the literature. Curr Infect Dis Rep 2008,10:515-521.
117. Norton WE, Amico KR, Fisher WA, Copenhaver MM, Kozal MJ, Cornman DH, et al. Attitudes toward
needle-sharing and HIV transmission risk behavior among HIV+ injection drug users in clinical care. AIDS Care
2008,20:462-469.
100.Fisher JD, Amico KR, Fisher WA, Harman JJ. The information-motivation-behavioral skills model of
antiretroviral adherence and its applications. Curr HIV/AIDS Rep 2008,5:193-203.
101. Amico KR, Harman JJ, O'Grady MA. Attrition and related trends in scientific rigor: a score card for ART
adherence
intervention research and recommendations for future directions. Curr HIV/AIDS Rep 2008,5:172-185.
102. Amico KR, Konkle-Parker DJ, Cornman DH, Barta WD, Ferrer R, Norton WE, et al. Reasons for ART non-adherence
in the Deep South: adherence needs of a sample of HIV-positive patients in Mississippi. AIDS Care
2007,19:1210-1218.
103. Starace F, Massa A, Amico KR, Fisher JD. Adherence to antiretroviral therapy: an empirical test of the
information-motivation-behavioral skills model. Health Psychol 2006,25:153-162.
104. Kozal MJ, Amico KR, Chiarella J, Cornman D, Fisher W, Fisher J, et al. A population-based and longitudinal study
of sexual behavior and multidrug-resistant HIV among patients in clinical care. MedGenMed 2006,8:72.
105. Fisher JD, Fisher WA, Cornman DH, Amico RK, Bryan A, Friedland GH. Clinician-delivered intervention during
routine clinical care reduces unprotected sexual behavior among HIV-infected patients. J Acquir Immune Defic
Syndr 2006,41:44-52.
106. Fisher JD, Fisher WA, Amico KR, Harman JJ. An information-motivation-behavioral skills model of adherence to
antiretroviral therapy. Health Psychol 2006,25:462-473.
107. Amico KR, Harman JJ, Johnson BT. Efficacy of antiretroviral therapy adherence interventions: a research
synthesis of trials, 1996 to 2004. J Acquir Immune Defic Syndr 2006,41:285-297.
108. Amico KR, Fisher WA, Cornman DH, Shuper PA, Redding CG, Konkle-Parker DJ, et al. Visual analog scale of ART
adherence: association with 3-day self-report and adherence barriers. J Acquir Immune Defic Syndr
2006,42:455-459
109. Kozal MJ, Amico KR, Chiarella J, Cornman D, Fisher W, Fisher J, et al. HIV drug resistance and HIV transmission
risk behaviors among active injection drug users. J Acquir Immune Defic Syndr 2005,40:106-109.

16
 110. Harman JJ, Amico KR, Johnson BT. Standard of care: promoting antiretroviral adherence in clinical care. AIDS
Care 2005,17:237-251.
111. Amico KR, Toro-Alfonso J, Fisher JD. An empirical test of the information, motivation and behavioral skills model
of antiretroviral therapy adherence. AIDS Care 2005,17:661-673.
112. Kozal MJ, Amico KR, Chiarella J, Schreibman T, Cornman D, Fisher W, et al. Antiretroviral resistance and high-risk
transmission behavior among HIV-positive patients in clinical care. Aids 2004,18:2185-2189.
113. Fisher JD, Cornman DH, Osborn CY, Amico KR, Fisher WA, Friedland GA. Clinician-initiated HIV risk reduction
intervention for HIV-positive persons: Formative Research, Acceptability, and Fidelity of the Options Project. J
Acquir Immune Defic Syndr 2004,37 Suppl 2:S78-87.
114. Amico KR, Bruch MA, Haase RF, Sturmer PJ. Trait shyness, actual-ought self-discrepancy and discomfort in social
interaction. Journal of Personality and Individual Differences 2004,36:14.

CHAPTERS

1. Tolley EE, Friedland BA, Gafos M, Amico KR, Van Damme L, Woodsong C, et al. (2015). Socioeconomic and
Behavioral Factors Influencing Choice, Adherence and Success of Microbicide Formulations. In: Drug Delivery and
Development of Anti-HIV Microbicides. Edited by Neves Jd, Sarmento B: Pan Stanford Publishing. 569-601.
2. Amico KR. (2014). Adherence to HIV Treatment as Prevention and PreExposure Prophylaxis. In S. Kalichman & L.
Eaton (Eds). Biomedical Advances in HIV Prevention.
3. O'Connell, A. A. & Amico, K.R. (2010) Logistic Regression. In Gregory R. Hancock and Ralph O. Mueller (Eds.),
Quantitative Methods in the Social and Behavioral Sciences: A Guide for Researchers. Mahwah, NJ: Lawrence
Erlbaum Associates.
4. Simoni, J., Amico, K.R., Pearson, C. R., & Malow, R. M. (2008). Overview of Adherence to Antiretroviral Therapies. In
Pope C., R. White, & Malow R. (Eds.), Global Frontiers in Prevention/Intervention. New York, Taylor & Francis
Publications, Inc.; release date July 2008, pp. 191-200.
5. Amico, K. R., & Johnson, B. T. (2003). Prevention of HIV/AIDS in older and elderly populations, In T. Gullotta & M.
Bloom (Eds.). Encyclopedia of Primary Prevention and Health Promotion.
6. Rivet, K. M. (1998). Shyness and self-discrepancy: A mediated model. Doctoral dissertation at the University at
Albany, Albany, New York.

SELECT PRESENTATIONS

1. Amico, KR. Adherence to Prevention: Behavioral drivers of adherence. Session chair and invited speaker. Adherence
to HIV Prevention and Treatment: Key populations in sub-Saharan Africa. (April 26-27, 2018). Harare, Zimbabwe.
2. Amico, KR. PrEP: Community awareness, building demand, expanding access and supporting effective use. Invited
talk. Michigan PrEP Working Group. (October 5, 2017). Detroit, MI, US.
3. Amico, KR. The IMB model situated to engagement in care: Social and behavioral science in health research and
practice. Invited lecture. University of Alabama Birmingham (September 29, 2017). Alabama, US
4. Amico, KR. Expanding HIV prevention; What’s stopping you? Primary care and infectious disease: Working together
to end the HIV and HCV Epidemics. ANAC Michigan Chapter. (September 23, 2017). Mount Pleasant, MI, US.
5. Amico KR. Beyond antiretrovirals: Social behavioral science for attaining 90-90-90. 90-90-90 Targets Workshop. (July
22-23, 2017). Paris, France.
6. Patel R, …Amico KR (senior author). Self-report and medication possession ratio are accurate measures of HIV pre-
exposure prophylaxis use in a real-world clinic setting. 10th IAS Conference on HIV Pathogenesis, Treatment and
Prevention. July 2017. Paris. France.

17
7. Amico KR. Challenges to and opportunities for PrEP uptake: What have we learned? What gaps must we fill?
Controlling the HIV Epidemic with Antiretrovirals: Leveraging progress, seizing opportunities. International
Association of Providers of AIDS Care. 13-14 October 2016, Geneva Switzerland.
8. Amico KR. Sex-positive dialogue and comprehensive HIV prevention: A packaged deal. 11th International Conference
on HIV Treatment and Prevention Adherence. International Association of Providers of AIDS Care. 9-11 May 2016,
Miami FL.
9. Amico, KR. Conceptual models and behavioral frameworks in adherence: Needs assessment, interventions and
quality improvement. Therapeutic Adherence Conference: Understanding and improving treatment adherence: an
interdisciplinary approach. February 26th 2016. University of Alabama Birmingham, Alabama.
https://www.youtube.com/watch?v=X5_jG0m-fPo&feature=youtu.be
10. Amico KR. Raising PrEP Awareness: A very brief overview and call to action. Michigan HIV/AIDS Council, Black AIDS
Awareness Campaign KICK OFF. February 4th 2016
11. Landovitz RJ, Amico KR, Psaros C, Safren SA, Kofron R, Flynn R, Bolan R, Jordan W, Mayer KH, Dierst-Davis R,
Rawlings MK, Bushman L, Anderson P, Wohl AR. Real-time Biomarkers of TDF/FTC Adherence Support a Staged-
intensity Adherence Support Intervention in a PrEP Demonstration Project. 2015 National HIV Prevention
Conference. December 8, 2015. Atlanta, GA
12. Amico KR. What are we trying to prevent and where tools fit. Envisioning comprehensive HIV prevention service
delivery in the US. TAG (Treatment Action Group) and HIV Prevention Justice Alliance Webinar. December 17 2015.
http://www.treatmentactiongroup.org/sites/g/files/g450272/f/201512/TAG-Webinar-12.17.15.pdf
13. Amico KR. Pre-exposure Prophylaxis: Research, Implementation and Advocacy. CHIP Lecture Series. November 16
2015. Storrs, CT.
https://mediasite.dl.uconn.edu/Mediasite/Play/53a6bec9150945f9a2f2da2de01c97631d
14. Amico KR. What will it take to optimize TasP, Achieve 90-90-90 and Control HIV. Controlling the HIV Epidemic with
Antiretrovirals: Having the Courage of our Convictions. October 1-2, 2015. Paris, France.
http://www.iapac.org/tasp_prep/presentations/TPSparis15-Panel-Amico.pdf
15. Amico KR. Adherence in HIV treatment and prevention- optimizing success through social-behavioral pathways.
Testing to Treatment: Implementing the full spectrum of HIV prevention and Care. Center for AIDS Intervention
Research (CAIR). September 16 2015. Milwaukee, Wisconsin. http://www.mcw.edu/cair/2015-Conference.htm
16. Amico KR. Adherence counseling approaches utilized in prior HIV prevention trials. NIH Optimization of Adherence
after VOICE meeting. September 1-2, 2015. Bethesda, MD
http://www.mtnstopshiv.org/sites/default/files/attachments/Rivet%20Amico.pdf
17. Amico KR. PrEP experiences among South African women in the HPTN067 (ADAPT) study: Healthy paranoia
(skepticism), Ubuntu, champions and challenges to resolving PrEP dissonance. 8th IAS Conference on HIV
Pathogenesis, Treatment and Prevention. 20 July 2015. Vancouver, Canada.
https://www.youtube.com/watch?v=1nFO2r2sO88
18. Wallace M, Bekker LG, Roux S, Atujuna M, Sebastian E, Dye BJ, Elharrar V, Grant R, Amico KR. PrEP Ubuntu’ and
Experiences with open-label PrEP Among African Women. Poster. 8th IAS Conference on HIV Pathogenesis,
Treatment and Prevention. 20 July 2015. Vancouver, Canada.
19. Franks J, Hirsch-Moverman Y, Loquere AS, Amico KR, Dye BJ, McKinstry L, Grant RM, Mannheimer SB. Patterns of Sex
and PrEP in Harlem MSM: A qualitative study (HPTN 067). 8th IAS Conference on HIV Pathogenesis, Treatment and
Prevention. 20 July 2015. Vancouver, Canada.
20. Amico KR. Individual counseling interventions to promote ART adherence. Bill and Melinda Gates Foundation
Consultation Meeting. July 18th 2015. Vancouver, Canada.
21. Amico, KR. If you build it, will they come? A model of mutuality. Invited talk at Accelerating Prevention in
Adolescents. NIAID/NIH. June 22-23, 2015. Rockville, MD
22. Ledford G, Coleman M, Schmandt J, Amico KR, Cohen S, Matheson T, Bacon O, Liu A, Elion R. Reflections on Risk: A
Qualitative Analysis of Counseling Notes from The PrEP Demo Project in Washington, DC . 10th International
Conference on HIV Treatment and Prevention Adherence. IAPAC. June 30 2015. Miami, FL.

18
23. Kallen MA, Amico KR, Stanley MA, Cully JA, Davila JA, Giordano TP. Does a baseline Information-Motivation-Behavior
Skills (IMB) model of “retention in HIV care” predict retention in care and HIV viral load improvement at six months
in hospitalized, out-of-care persons living with HIV? 10th International Conference on HIV Treatment and Prevention
Adherence. IAPAC. (June 30 2015). Miami, FL.
24. Amico, KR. Developing an “HIV prevention cascade”: Current approach and future directions. 10th International
Conference on HIV Treatment and Prevention Adherence. Plenary 10th International Conference on HIV Treatment
and Prevention Adherence IAPAC. June 30 2015. Miami, FL.
http://iapac.org/AdherenceConference/presentations/ADH10_Plenary4-Amico.pdf
25. Amico KR, McMahan V, Mehrotra M, Anderson PL, Guanira J, Veloso V, Grant RM for the iPrEx study team. Self-
Reported Recent PrEP Use Has Strong Relation to Drug Detection in iPrEx OLE. Poster 977 presented at the
Conference on Retroviruses and Opportunistic Infections (CROI); February 23rd – February 26th, 2015; Seattle,
Washington, USA
26. Bekker LG, Hughes J, Amico KR, Roux S, Hendrix C, Anderson PL, Dye B, Elharrar V, Stirratt MJ, Grant RM. HPTN
067/ADAPT Cape Town: A Comparison of Daily and Nondaily PrEP Dosing in African Women. Poster 978LB presented
at the Conference on Retroviruses and Opportunistic Infections (CROI); February 23rd – February 26th, 2015; Seattle,
Washington, USA
27. Glidden DV, Buchbinder SP, Anderson PL, McMahan V, Amico KR, Liu A, Hosek S, Mehrotra M, Grant RM. PrEP
Engagement for HIV Prevention: Results From the iPrEx Open Label Extension (OLE). Poster 970 presented at the
Conference on Retroviruses and Opportunistic Infections (CROI); February 23rd – February 26th, 2015; Seattle,
Washington, USA
28. Chianese C, Amico KR, Mayer K, Liu A, McMahan V, Hosek S, et al. Integrated Next Step Counseling for sexual health
promotion and medication adherence for individuals using pre-exposure prophylaxis. AIDS Res Hum Retroviruses
2014, 30 Suppl 1:A159.
29. Amico KR. Antiretroviral adherence and young adults. Joint HPTN-IMPAACT Plenary Session. (June 18 2014).
Arlington, VA.
http://www.hptn.org/web%20documents/AM2014Present/JP/06AmicoAdolescentART18Jun14.pdf
30. Amico, KR.. Increasing PrEP Awareness in the US: The Development and Implementation of Five Resources: PrEP REP.
Preconference symposium. 9th International Conference on HIV Treatment and Prevention Adherence. IAPAC. (June 8
2014). Miami, FL.
http://www.iapac.org/AdherenceConference/presentations/ADH9_Sat2_Amico.pdf
31. Amico KR., Balthazar C., Coggia T., Hosek S. PrEP Audio Visual Representation (PrEP REP): Development and pilot of
a PrEP education video. 9th International Conference on HIV Treatment and Prevention Adherence. IAPAC. (June 8-
10 2014). Miami, FL.
http://www.iapac.org/AdherenceConference/presentations/ADH9_OA386.pdf
32. Amico KR, Marcus J. PrEP adherence: Lessons from clinical trials, antiretroviral treatment adherence, and biomedical
prevention studies. HPTN Principle Investigators Series webinar. (January 8 2014).
33. Amico, KR. Risky Women: Disrupting simple notions of women’s HIV-risk. US Women and PrEP Working Group
webinar. (December 9, 2013).
http://www.avac.org/sites/default/files/event_files/K%20Rivet%20Amico%20Slides%20Dec9%202013%20Webinar.
pdf
34. Amico KR. PrEP Adherence: Elements of Success. Controlling the HIV epidemic with Antiretrovirals: Evidence
Summit. (September, 2013). London, UK.
http://www.iapac.org/tasp_prep/presentations/TPSlon13_Plenary9_Amico.pdf
35. Amico KR. A brief overview of implementation challenges and opportunities. (June, 2013). New York State-
International Training and Research Program 20th Alumni Reunion. Kiev, Ukraine
36. Amico KR. Antiretroviral adherence: Correlates, models and intervention strategies. (June, 2013 New York State-
International Training and Research Program 20th Alumni Reunion. Kiev, Ukraine

19
37. Amico KR. Adherence measurement in PrEP trials. (May, 2013). Invited presentation for the Community working
group at the annual HPTN meeting. Washington, DC.
38. Amico KR. ART adherence in US women living with HIV: Overview and intervention approaches. (April, 2013).
Women’s Research Initiative on HIV/AIDS. Calistoga, CA.
39. Amico KR. Bio-psycho-social pathways in the continuum of HIV care: Strategies to promote engagement. (December
2013). Invited lecture at Vanderbilt Institute for Global Health, Nashville Tennessee, and Baylor College of Medicine,
Huston Texas.
40. Amico KR, Marcus J, McMahan V, J, Goicochea P, Koester K, Vargas L, Grant R, Mayer K, Buchbinder S, Liu A.
(November 26-28, 2012). Near-perfect adherence in US iPrEx RCT sites: Frequency and Correlates [#90]. Forum for
collaborate HIV research. 2012 National Summit on HIV and Viral Hepatitis Diagnosis, Prevention and Access to Care.
November 26-28, 2012. Washington DC.
http://www.hivforum.org/storage/documents/_2012NationalSummit_Posting/b_01_05_amico.pdf
41. Amico KR. (July, 2012). Education and counseling to support adherence with general population of PLWH; Guidelines
and recommendations for implementation. AIDS 2012 XIX International AIDS Conference, Washington DC US.
42. Amico KR, Marcus J, McMahan V, Goicochea P, Vargas L, Grant R, Liu A. (July, 2012). Correlates of study product use
among US participants in the iPrEx randomized controlled trial of daily oral preexposure prophylaxis. AIDS 2012 XIX
International AIDS Conference, Washington DC US.
http://www.iprexnews.com/content/aids2012/embargados/Correlates%20of%20Study%20Produc%20Use%20in%2
0iPrEx%20AIDS%202012.pdf
43. Amico KR. (June, 2012). Behavioral threats to PrEP success. TasP PrEP Evidence Summit: Controlling the HIV
pandemic with Antiretrovirals. Royal Gardens, London, UK.
http://www.iapac.org/tasp_prep/presentations/TPSlon12_Plenary8_Amico.pdf
44. Simoni, J. M., Amico, K. R., & Pantalone, D. (2012, June). Antiretroviral adherence interventions: A review of reviews
since 2005. Presentation at the HIV/AIDS Network Coordination Behavioral Science Working Group Meeting, Miami,
FL.
45. Simoni, J. M., Amico, K. R., & Marrazzo, J. (2012, June). Adherence in Pre-Exposure Prophylaxis (PrEP) and
Microbicide Trials. Presentation at the HIV/AIDS Network Coordination Behavioral Science Working Group Meeting,
Miami
46. Amico KR, JM Zuniga (June, 2012). Bridging practice and research: A survey of evidence-based practices used in HIV
care for linkage, retention and adherence support [80466]. Oral presentation at the 7th Annual HIV Treatment and
Prevention Adherence Conference of the International Association of Providers in AIDS Care, Miami, FL.
47. Amico KR, McMahan V, Marcus J, Goicochea P, Vargas L, Grant R, Liu A. (June, 2012). Integrated Next Step
Counseling (iNSC): A discussion based sexual health promotion conversation to support men who have sex with men
using PrEP in the iPrEx open label extension [80467]. Oral presentation at the 7th Annual HIV Treatment and
Prevention Adherence Conference of the International Association of Providers in AIDS Care, Miami, FL.
48. Lui A, Colfax G, Cohen S, Bacon O, Kobler M, Amico KR, Mugavero M, Grant R, Buchbinder S. (June 2012). The
spectrum of engagement in HIV prevention: Proposal for a PrEP cascade [80040]. Presented at the 7th Annual HIV
Treatment and Prevention Adherence Conference of the International Association of Providers in AIDS Care, Miami,
FL.
49. Horvath K, Rosser BR, Dakes JM, Konstan J, Danilenko G, Vezina H, Amico KR, Simoni J, Williams M. (June, 2012).
Rsults of an online social support and text reminder ART intervention [79984]. Presented at the 7th Annual HIV
Treatment and Prevention Adherence Conference of the International Association of Providers in AIDS Care, Miami,
FL.
50. Mark D, Amico KR, Orrell C, Bekker LG, Kaplan R. (June 2012). A counseling package for reintegrating patients into
care after loss to follow-up: Return to care counseling and the self-care course. Poster 79978 at the 7th Annual HIV
Treatment and Prevention Adherence Conference of the International Association of Providers in AIDS Care, Miami,
FL.

20
51. Konkle-Parker D, Amico KR, McKinney V. (June 2012). A multi-dimensional intervention improves retention in HIV
care. Poster 79991 at the 7th Annual HIV Treatment and Prevention Adherence Conference of the International
Association of Providers in AIDS Care, Miami, FL.
52. Simoni J, Amico KR, Pantalone D. (June 2012). Antiretroviral adherence interventions: A review of reviews since
2005. Poster 79994 at the 7th Annual HIV Treatment and Prevention Adherence Conference of the International
Association of Providers in AIDS Care, Miami, FL.
53. Marcus J, Amico KR, Golub S, Fuchs J, Horvath T, Grant R, Buchbinder S, Reingold A, Liu A. (June 2012). Potential
interventions to support adherence to HIV pre-exposure prophylaxis: A systematic review. Poster 79997 at the 7th
Annual HIV Treatment and Prevention Adherence Conference of the International Association of Providers in AIDS
Care, Miami, FL.
54. Simoni J, Amico KR, Marrazzo J. (June 2012). How adherence research on ART can inform PrEP: Lessons from our
missteps and success. Poster 80007 at the 7th Annual HIV Treatment and Prevention Adherence Conference of the
International Association of Providers in AIDS Care, Miami, FL.
55. Smith L, Amico KR, Shuper P, Christie S, Fisher W, Cornman D, Doshi M, MacDonald S, Pillay, Fisher J. (June 2012).
Psychosocial factors influencing early engagement and retention in pre-ART clinical care in KwaZulu-Natal, South
Africa. Poster 80045 at the 7th Annual HIV Treatment and Prevention Adherence Conference of the International
Association of Providers in AIDS Care, Miami, FL.
56. Catz S, Amico KR, Balderson B, Hogan P, Horberg, Mahoney C, McClure J, Silverberg M, Ralston J. Individually
tailoring a health information technology adherence intervention using patient-reported web survey responses.
Poster 80067 at the 7th Annual HIV Treatment and Prevention Adherence Conference of the International
Association of Providers in AIDS Care, Miami, FL.
57. Amico KR. (October 12, 2011). Biomedical HIV-Prevention Product Use in Blinded and Open Label Trials: Support
strategies and future directions. Invited webinar presentation for HIV/AIDS Network Coordination (HANC).
58. Amico KR. (May 24, 2011). Adherence in biomedical prevention trials. Presented at the 6th Annual HIV Treatment
Adherence Conference of the International Association of Providers in AIDS Care, Miami, FL.
59. Amico KR. (May 24, 2011). Strengthening prevention adherence in NAID and DAIDS Network Trials. Presented at the
6th Annual HIV Treatment Adherence Conference of the International Association of Providers in AIDS Care, Miami,
FL.
60. Amico KR, Anderson PL, Liu A, McMahan V, Buchbinder S, Lama JR, Guanira J, Zheng JH, Montayo O, Casapia M, Brag
L, Bishman L, Gidden D, Goicochea P, Vargas L, Grant RM, for the iPrEx study team. (May 23, 2011). Defining and
Predicting Detection Rates of Intracellular Emtricitabine-Triphosphate (FTC-TP) and Tenofovir-Diphosphate (TDF-DP)
in the iPrEx HIV Pre-Exposure Prophylaxis (PrEP) Trial. Top three abstract submission recipient, presented at the 6th
Annual HIV Treatment Adherence Conference of the International Association of Providers in AIDS Care, Miami, FL.
61. Amico KR. (March 27th, 2011). The VOICE Adherence Strengthening Program (VASP). Annual Microbicides Trials
Network meeting. Washington DC.
62. Amico KR, Liu A, McMahan V, Anderson PL, Lama JR, Guanira J, Zheng JH, Goicochea P, Vargas L, Glidden D, Grant
RM for the iPrEx investigators. Adherence Indicators and Pre-exposure Prophylaxis (PrEP) Drug Levels in the iPrEx
Study. Presented at the 18th Conference on Retroviruses and Opportunistic Infections (CROI); February 27th – March
2nd, 2011; Boston Massachusetts, USA
63. Amico KR. Next Step Counseling: Promoting daily PrEP use in the iPrEx study. (2010, September). Invited
presentation. Microbicide Trials Network. Washington DC, USA.
64. Amico KR. Neutral Assessment: A strategy to promote comfort in accurate reporting of PrEP use in the iPrEx study.
(2010, September). Microbicide Trials Network. Washington DC, USA.
65. Amico KR. HIV School Romania (2010) Antiretroviral Adherence: The Information Motivation Behavioral Skills model
of ART Adherence (IMB). (2010, September). Baylor Center of Excellence Black Sea Foundation Annual HIV School.
Constanta, Romania.

21
66. Ferris, A.M., K. Lora, R. Aseltine, and R. Amico. (2010, June). Effectiveness of an IMB-based intervention for reducing
sweetened beverage consumption in pre-school children. Proceeding USDA/NRI annual meeting. Denver, CO.
6/21/2010.
67. Amico KR. 7 of the 700 things I learned at IAPAC 2010. (2010, May). Presented at the 5th Annual HIV Treatment
Adherence Conference of the International Association of Providers in AIDS Care, May 2010, Miami, FL.
68. Amico KR, Giordano T, Mugavero M, Safren S, Simoni J, Smith L, Wilson I. (2010, May). Building Blocks for
Interventions: Explanatory and delivery models in ARV adherence and HIV-care utilization. Workshop presented at
the 5th International Conference on Treatment Adherence, Miami, FL.
69. Amico KR, L Smith, J Urso, V Odesina, V Diaz, S Kwon, K Dieckhaus. (2010, May). The situated Information Motivation
Behavioral Skills model of Care Initiation and Maintenance. Oral presentation at the 5th International Conference on
Treatment Adherence, Miami, FL.
70. Amico KR, L Smith, J Urso, V Odesina, V Diaz, S Kwon, K Dieckhaus. (2010, May). Retention in HIV-Care: Correlates of
Gaps in HIV-Care. Poster presentation at the 5th International Conference on Treatment Adherence, Miami, FL.
71. Smith, L.R., Amico, K. R., Fisher, J. D., *Diaz, V., *Hudd, K., *Lee, G.S., Cunningham, C. O. Retention and Re-
engagement in HIV Clinical Care in an Inner-City Population: A qualitative theory-based approach to understanding
core facilitators and barriers to care utilization. Poster session presented at the 5th International Conference on HIV
Treatment Adherence, May 22-25, 2010, Miami Beach, Florida.
72. Amico KR, McMahan V, Goicochea P, Vargas L, Wolf E, Lama J, Grant R, Liu A. (2010, May). Developing an Innovative
Approach to Adherence Counseling and Assessment in a Pre-Exposure Prophylaxis (PrEP) Trial: Next Step Counseling
and Neutral Assessment in the iPrEx Study. Oral presentation at the 5th International Conference on Treatment
Adherence, Miami, FL.
73. Amico, K.R. (2010, May). How can we better disseminate and implement efficacious adherence interventions?
Invited moderator at the 5th Annual HIV Treatment Adherence Conference of the International Association of
Providers in AIDS Care, April 2009, Miami, FL.
74. Amico KR. (2010). Adherence Promotion to ARVs and in the context of PrEP trials: Intervening to promote adherence
and pill-taking. Invited presentation at the HIV/AIDS Network Coordination Behavioral Working Group meeting,
January 26th 2010, San Francisco.
75. Amico KR. Next-Step Counseling for PrEP Use: Understanding and Promoting Pill-Taking Behavior in iPrEx. Presented
at the iPrEx Investigator Meeting, November 12th-14th 2009, San Francisco, CA.
76. Norton, W. E., Amico, K. R., Fisher, W. A., Cornman, D. H., Shuper, P. A., Trayling, C., Redding, C., Ferrer, R. A., &
Fisher, J. D. (2009, September). Information, motivation, and behavioral skills barriers associated with intentional vs.
unintentional ARV non-adherence behavior among HIV-positive patients in clinical care. Paper presented at the AIDS
Impact Conference, Gaborone, Botswana.
77. Ferris, A.M., M.P. Pierce, K. Lora, L.S. Goodell, K.R. Amico, E. Havens. (2009, June). Effectiveness of an IMB-based
intervention for reducing sweetened beverage consumption in pre-school children. Proceeding USDA/NRI annual
meeting. Baltimore: MD, 6/12/2009.
78. Amico KR, Harman JJ, O’Grady M, Johnson B. Research Synthesis of ART Adherence Interventions: A Synthesis of
Published Adherence Intervention Outcomes Research from 1996 to September 2007. (2009, April). Presented at the
4th Annual HIV Treatment Adherence Conference of the International Association of Providers in AIDS Care, April
2009, Miami, FL.
79. Amico, K.R. (2009, April). How can we better disseminate and implement efficacious adherence interventions?
Invited moderator at the 4th Annual HIV Treatment Adherence Conference of the International Association of
Providers in AIDS Care, April 2009, Miami, FL.
80. Amico, K.R. (2009, April). Options for Adherence. Presented in the Introduction to Motivational Enhancement
Techniques for Adherence Counseling Workshop, D Konkle-Parker, C Golin, KR Amico, M Demers, V McKinney, N

22
 Brown, K Amola, C Grodensky at the 4th Annual HIV Treatment Adherence Conference of the International
Association of Providers in AIDS Care, April 2009, Miami, FL.
81. Amico KR, Simoni J, Wilson I, Malow RM, Devieux J, & Deschamps A. Monitoring Patient Adherence:
Recommendations from and for Practice. The 4th Annual International Conference on HIV Treatment Adherence,
International Association of Providers in AIDS Care, April 2009: Miami, FL
82. Amico KR, Fisher WA, et al. Impact of an IMB Model Based Adherence Promotion Software Intervention on
Adherence Over Time: Outcomes of the LifeWindows Project. Presentation at the 4th Annual HIV Treatment
Adherence Conference of the International Association of Providers in AIDS Care. April 6th 2009, Miami, FL.
83. Amico, K.R. (2009, March). Engagement in Care for Chronic Medical Conditions- The Case of HIV. Invited
presentation, Wayne State University, Clinical Lecture Series, Detroit, MI.
84. Amico, K.R. (2008, October). Adherence in Chronic Medical Conditions: Intervening to promote engagement in care.
Invited presentation, University of Connecticut, Department of Psychology, Clinical Psychology Lecture Series, Storrs,
CT.
85. Amico, K.R. (2008, March). How can we better disseminate and implement efficacious adherence interventions?
Invited moderator at the NIMH/IAPAC International Conference on HIV Treatment Adherence, Jersey City, NJ.
86. Amico, K.R. (2008, April 7th). The LifeWindows Antiretroviral Adherence Intervention Software Package: Applications
for case-managers. Invited presentation to Ohio State AIDS Education and Training Center, Southeastinc. Columbus,
Ohio.
87. Goodell, L.S., K.R. Amico, M.B. Pierce, and A.M. Ferris. (2008) An information-motivation-behavioral skills model for
child sweetened beverage consumption. FASEB J (Abstract 678)
88. Norton, W.E., Amico, K.R., Copenhaver, M., Cornman, D.H., Fisher, J.D., Fisher, W.A., Friedland, G., & Kozal, M.
(2007, July). Injection drug use risk behavior and attitudinal correlates in a sample of HIV+ patients in clinical care:
Avenues for intervention. Presented at the International AIDS Impact Conference, Marseille, France.
89. Fisher, J. D., Amico, K. R., & Shuper, P. A. (2007, March). Intervention demonstration: A CD-Rom delivered program
to improve adherence in HIV-infected clinic patients. Paper presented at the NIMH/IAPAC International Conference
on HIV Treatment Adherence, Jersey City, NJ.
90. Amico, K. R., Shuper, P. A., Cornman, D. H., Fisher, J. D., Fisher, W. A., Colon, R., Redding, C. G., & Trayling, C.
A. (2007, March). Patterns of use of a computer-delivered adherence intervention: Preliminary results from the
LifeWindows Project. Paper presented at the NIMH/IAPAC International Conference on HIV Treatment Adherence,
Jersey City, NJ.
91. Shah AD, Kyriakides T, Amico KR, Chiarella J, Friedland G, & Kozal MJ. (2006, June). Cumulative Prevalence of HIV
Drug Resistance in HIV+ Patients in Clinical Care. 15th International HIV drug resistance workshop. June 13-17. Sitges,
Spain.
92. Konkle-Parker, D.J., Amico, K.R., Barta, W., Cornman, D.H., Fisher, W.A., Norton, W., & Trayling, C. (2006, May). ARV
Adherence Needs in a Deep South Clinic Population. Poster presented at the International Association of Physicians
in AIDS Care, Chicago, IL.
93. William D. Barta WD, Amico KR, Konkle-Parker D, Fisher WA, Fisher JD, & Shuper S. (2006, March). Development
and validation of an assessment of antiretroviral adherence information, motivation, and behavioral skills. Society of
Behavioral Medicine 27th Annual Meeting & Scientific Sessions, San Francisco, CA
94. Shuper, P.A., Fisher, J.D., Cornman, D.H., Amico, K.R, Fisher, W.A., Barta, W., Ferrer, B., Little, J., Norton, W.,
Redding, C.G., Trayling, C.A. (2006, March). Changing ART Adherence using Theory-Based, Computer-Delivered
Interventions. Conference presentation, National Institute of Mental Health/IAPAC International Conference on HIV
Treatment Adherence, Jersey City, NJ.
95. Kozal, M. J., Amico, K. R., Kyriakides, T., Chiarella, J., Schreibman, T., Fisher, J., Fisher, W., Cornman, D., & Friedland,
G. (2004, February). Continuing high risk sexual behavior and increasing antiretroviral resistance among HIV+
patients in care helps explain the rising prevalence of resistance among new HIV infections. 11th Annual Conference
on Retroviruses and Opportunistic Infections. San Francisco, CA

23
96. Kozal, M. J., Amico, K. R., Chiarella, J., Schreibman, T., Fisher, J. D., Fisher, W. A., Cornman, D., & Friedland, G. (2003,
June). Patients with Antiretroviral Resistant
HIV Infections Engaging in High Risk Transmission Behavior. Paper presented at the XII International HIV Drug
Resistance Workshop, Cabo del Sol, Los Cabos, Mexico.
97. Fisher, J.D., Fisher, W.A., Amico, K.R., & Harman, J.J. (2003, August) A model for conceptualizing adherence behavior.
Presentation at the South African AIDS Conference at the ICC, Durban, South Africa.
98. Kozal, M., Amico, K. R., Chiarella, J., Fisher, J., Cornman, D., Fisher, W. A., et al. (2002, July). Prevalence of
antiretroviral resistance in patients in clinical care reporting high risk HIV transmission behavior. Poster presented at
the XIV International AIDS Conference, Barcelona, Spain.
99. Cornman, D. H., Amico, K. R., Fisher, J. D., Fisher, W., A., & Friedland, G. H. (2002, July) The Options Project: A
healthcare provider-initiated risk reduction intervention for HIV-infected individuals in clinical care. Poster presented
at the XIV International AIDS Conference, Barcelona, Spain.
100. Fisher, J. D., Fisher, W. A., & Amico, K. R. (2001, July). An Information-Motivation-Behavioral Skills Model
of adherence to highly active antiretroviral therapy. Paper presented at AIDS Impact: Biopsychosocial Aspects of HIV
Infection 5th International Conference, Brighton, UK.
101. Friedland, G. H., Fisher, J. D., Fisher, W. A., Amico, K. R., & Cornman, D. (2001, July). Frequency, patterns
and correlates of HIV transmission risk behaviors among HIV seropositive patients in clinical care. Presented at the
1st IAS Conference on HIV Pathogenesis and Treatment, Buenos Aires, Argentina.
102. Amico, K. R., Cornman, D. H., Fisher, J. D., Fisher, W. A., & Friedland, G. (2001, July). Risk behaviors,
adherence, stages of change, and well-being in HIV positive patients in clinical care. Paper to presented at AIDS
Impact: Biopsychosocial Aspects of HIV Infection 5th International Conference, Brighton, UK.
103. Fisher, W. A., Fisher, J. D., Friedland, G., Cornman, D., & Amico, K. R. (2001, August). The Options Project: A
Physician-Delivered Intervention for HIV+ Individuals in Clinical Care Settings. Paper presented at the 2001 National
HIV Prevention Conference, Atlanta, Georgia
104. Amico, K. R., Cornman, D., Fisher, J. D., Fisher, W. A., & Friedland, G. (2001, August). The Options Project:
Computer-delivered assessment of risk behavior in HIV positive patients in clinical care. Paper and poster presented at
the 2001 National HIV Prevention Conference, Atlanta, Georgia.

WORKSHOPS/TRAININGS PROVIDED

1. Adherence Education, Regimen Planning and Group Facilitation- PHOENIx Study. Regional training. Lima, Peru. April
2018.
2. Adherence Education, Regimen Planning and Group Facilitation- PHOENIx Study. Regional training. Johannesburg,
South Africa. November 2017.
3. Health Scout MI training. In country training of project Health Scouts (community health workers) as co-trainer.
May 2-5, 2017. Kalisizo, Uganda.
4. Integrated Next Step Counseling and Targeted iNSC – TRIUMPH project: Demonstration project for PrEP in
transgender people. San Francisco CA, USA. 2017
5. AEGIS: PrEP Counseling for Women. Integrated Next Step Counseling and Targeted iNSC – CHRP PATH Project. Los
Angeles CA, USA. 2016, 2017
6. Integrated Next Step Counseling and Targeted iNSC – CHRP PATH Project (2013 November). Los Angeles CA, USA.
7. HPTN069 Wisepill Advised Adherence Counseling. Webinar (October 15th and 18th, 2013).
8. iEngage Intervention Workshop- Engaging HIV-care initiators using MI and advanced counseling strategies. iEngage
Project. University of Alabama (2013, May). Birmingham, Alabama, USA.
9. Integrated Next Step Counseling – CHRP CRUSH Project (2013 March). Oakland CA, USA.
10. Integrated Next Step Counseling – CHRP PATH Project (2013 March). Los Angeles CA, USA.

24
11. Peer Support for Linkage and Retention in HIV-care: CHINA MP3 HOME Intervention. (2013 Feb). Beijing, China.
12. Next Step Counseling and Neutral Assessment - ADAPT Study: HPTN067. (2013). Harlem NY, USA.
13. Train the Trainers. Integrated Next Step Counseling (iNSC). ATN110/113. (September 2012). Chicago IL, US.
14. Brief Adherence Support Discussions. Next PrEP- HPTN069. Web training. (2012, September-November).
15. Next Step Counseling and Neutral Assessment – ADAPT Study booster: HPTN067. (2012, May). Bangkok, Thailand.
16. Integrated Next Step Counseling – ATN (103/113). (2012, April). Bethesda, Maryland.
17. Next Step Counseling and Neutral Assessment – ADAPT Study: HPTN067. (2011, September). Bangkok, Thailand.
18. Next Step Counseling in FACTS - FACTS Trial. (2011, August 3-5). Johannesburg, SA.
19. Next Step Counseling and Neutral Assessment - ADAPT Study: HPTN067. (2011, June). Cape Town, South Africa.
20. Voice Adherence Strengthening Program- VOICE Trial. (2011, April). Johannesburg, SA.
21. Voice Adherence Strengthening Program- VOICE Trial. (2011, April). Durban, SA.
22. Voice Adherence Strengthening Program- VOICE Trial. (2011, April). Kampala, Uganda.
23. Voice Adherence Strengthening Program- VOICE Trial. (2011, April). Harare, Zimbabwe.
24. Integrated Next Step Counseling and Neutral Assessment- iPrEx trial. (2011, May). Guayaquil, Ecuador.
25. Integrated Next Step Counseling and Neutral Assessment- iPrEx Trial. (2011, March). Cape Town, SA.
26. Integrated Next Step Counseling and Neutral Assessment- iPrEx Trial. (2011, February). Boston, US.
27. Next Step Counseling and Neutral Assessment - iPrEx Trial. (2010, January). San Francisco, US 2009.
28. Next Step Counseling and Neutral Assessment for ARV adherence. (2010, July). Romania, 2010.
29. Next Step Counseling and Neutral Assessment - iPrEx Trial. (2009, November). Rio, Brazil 2009.
30. Next Step Counseling and Neutral Assessment- iPrEx Trial. (2009, September). Lima, Peru 2009.

PROFESSIONAL SERVICE
• Section Leader, International Adherence and Retention in Care Monitoring and Support Guidelines [IAPAC]
(2011-2012)
• International Adherence Conference co-chair (2014-2017)
• Treatment as Prevention Summit Planning team [IAPAC] (2012-current)
• Coordinating committee member for US PrEP and Women Working Group (member May 2013- current);
Coordinating committee member (Sept 2017 current);
• IMPAACT Adolescent Prevention Work Group Behavioral Science working group member (2014-current)
• IMPAACT Adherence Working Group chair (2015 current)
• Behavioral Science Advisory Groups (BSAG) HANC/NIMH (2014 – current)
• 2017 Consulting Editorial Board for AIDS and Behavior (January 2017 – current)
• Member PrEP Working Group (Detroit Metropolitan Area) (2017 -- current)
• Diversity Equity and Inclusion committee, Center for Sexuality and Health Disparities (2017)
• Wellness committee, Center for Sexuality and Health Disparities (2017)
• PrEP awareness volunteer, Unified (2015, 2016, 2017, 2018)
• School of Public Health Dean Search Committee (2017/2018)
• ATN Publications committee Review (April 2018 – current)
• Community Academic Research Network: Detroit Urban Research Center Member (April 2018 -- current)
• African Social Research Initiative Steering Committee Member (2017 – current)
• Reviewer for ASRI seed grants (February 2018)
• Reviewer for student internship awards Office of Global Public Health (April 2018)

25
MEMBERSHIPS
• American Psychological Association
• American Psychological Association Division 5
• ASRI
• CAR/URC
• PrEP Working Group MI

HONORS
Pioneers in AIDS response IAPAC 150 (2016)

REVIEWS (14 peer reviews May 1 2017 – April 30th 2018)

AIDS and Behavior (4)
AIBE-D-17-00050R1 8/1/2017
AIBE-D-16-00778R2 12/28/2017
AIBE-D-17-00992 1/20/2018
AIBE-D-18-00155 4/5/2018
Journal of Acquired Immune Deficiency Syndromes (2)
QAIV17942 5/29/2017
QAIV19697 2/24/2018
AIDS CARE (2)
AC-2017-03-0233 July 7 2017
AC-2017-09-0717 Nov 15 2017
Journal of AIDS & Clinical Research (1)
ACRGROUP-17-499 7/17/2017
JAMA (1)
JAMA-17-10363 1/20/2018
PLOS One (1)
PON-D-17-22742 12/5/2017
Journal of Medical Internet Research (2)
10274 3/26/2018
8811 3/14/2918
Pediatrics (1)
2018-0352 3/17/2018

GRANT REVIEWS
NIH PAR-16-117 iKNOW HIV Applications ZRG1 AARR-N 02
July 18, 2017

CONFERENCE REVIEWER
AIDS 2018 Abstract Reviewer
IAPAC Adherence Conference Abstract Reviewer

EXTERNAL REVIEWER FOR PROMOTION

Review for Full Professor Promotion: Rachel Vreeman, MD, MS, Indiana University School of Medicine

26
 Review of Associate Professor Promotion: Andres Camacho-Gonzalez, MD, MSc, Emory School of Medicine

INTERNAL REVIEWER AT UMICH

Faculty – 3rd year review for assistant professor HBHE (April 2018)

MENTORSHIP
MPH HBHE Students
Jessica Milne MPH April 2018: 4 Letters of Support/Recommendation (grants and employment)
Surabhi Rajaram MPH: Letter of recommendation (PhD programs)
Hannah Brady MPH April 2018: Letter of reference (employment)
Sami Shalabi MPH dual degree student: Letter of recommendation (employment)
Angela Knudson MPH: Letter of recommendation (employment)
K23 awardees mentored
Charlene Flash, MD, UAB
Bich Dang, MD, Baylor College of Medicine
Greer Burkholder, MD, UAB
Latesha Elopre, MD, UAB
Carolyn Audet, PhD. Vanderbilt University
International Scholars
Mercy T Mutambanengwe, University of Zimbabwe College of Health Sciences Clinical Trials Research Centre
HIV Prevention Trials Network Scholars
Victoria D. Ojeda, PhD, MPH, Univ. of California, San Diego

27